SEC Form 4
Vericel Corporation (VCEL) insider trading
In the 12 months to Nov 7, 2026, 8 VCEL insiders reported open-market sales of $7.7M across 25 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $7.7M
- 25 filings · 8 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 23 of 25
- $7.1M of $7.7M sold (93%)
Who traded VCEL, and when
- Sale
- Sale, pre-arranged (10b5-1)
VCEL daily close from Nov 7, 2025 to Nov 6, 2026, between $29.34 and $54.62, last $54.62. 25 sale and 0 purchase filings by 8 insiders, marked at their filing dates. Michael Halpin, Chief Operating Officer: sold $2.0M across 6 filings, first filed Nov 10, 2025, last Aug 5, 2026. Sean C. Flynn, Chief Legal Officer: sold $2.0M across 3 filings, first filed Mar 4, 2026, last Jun 30, 2026. Kevin F. Mclaughlin, Director: sold $1.1M across 4 filings, first filed Nov 12, 2025, last Aug 14, 2026. Jonathan Mark Hopper, Chief Medical Officer: sold $564.3K across 4 filings, first filed Dec 4, 2025, last Jun 30, 2026. Jonathan Siegal, Principal Accounting Officer: sold $530.8K across 3 filings, first filed May 8, 2026, last Jul 31, 2026. Paul K. Wotton, Director: sold $516.9K across 2 filings, first filed Dec 4, 2025, last May 13, 2026. 2 others: sold $912.4K across 3 filings, first filed Mar 25, 2026, last Jun 30, 2026.
Largest mark · tap a row for others
Sean C. Flynn · Chief Legal Officer
Sale $753,530
21,421 shares at $35.18 avg
Filed Mar 4, 2026 · traded Mar 2
Pre-arranged (10b5-1) · close on filing date $34.96
Michael Halpin · Chief Operating Officer
Chief Operating Officer
$2.0M soldSean C. Flynn · Chief Legal Officer
Chief Legal Officer
$2.0M soldKevin F. Mclaughlin · Director
Director
$1.1M soldJonathan Mark Hopper · Chief Medical Officer
Chief Medical Officer
$564.3K soldJonathan Siegal · Principal Accounting Officer
Principal Accounting Officer
$530.8K soldPaul K. Wotton · Director
Director
$516.9K sold2 others
Combined, one mark per week
$912.4K soldOpen-market trades
25 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Michael Halpin | Chief Operating Officer | $2.0M | — | 6 | 100% of sales | |
| Sean C. Flynn | Chief Legal Officer | $2.0M | — | 3 | 100% of sales | |
| Kevin F. Mclaughlin | Director | $1.1M | — | 4 | 100% of sales | |
| Jonathan Mark Hopper | Chief Medical Officer | $564.3K | — | 4 | 100% of sales | |
| Jonathan Siegal | Principal Accounting Officer | $530.8K | — | 3 | 100% of sales | |
| Paul K. Wotton | Director | $516.9K | — | 2 | — | |
| Heidi Hagen | Director | $486.1K | — | 1 | 100% of sales | |
| Joseph Anthony Mara Jr. | Chief Financial Officer | $426.3K | — | 2 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Kevin F. Mclaughlin Director | SalePre-arranged (10b5-1) | 7,000 | $44.53 | $311.7K | 18,300 | |
traded | Michael Halpin Chief Operating Officer | SalePre-arranged (10b5-1) | 10,000 | $46.84 | $468.4K | 16,394 | |
traded | Jonathan Siegal Principal Accounting Officer | SalePre-arranged (10b5-1) | 4,500 | $48.90 | $220.1K | 1,078 | |
traded | Sean C. Flynn Chief Legal Officer | SalePre-arranged (10b5-1) | 15,000 | $45.64 | $684.6K | 1,647 | |
traded | Jonathan Mark Hopper Chief Medical Officer | SalePre-arranged (10b5-1) | 5,000 | $45.00 | $225.0K | 75,753 | |
traded | Joseph Anthony Mara Jr. Chief Financial Officer | SalePre-arranged (10b5-1) | 5,000 | $44.75 | $223.8K | 16,009 | |
traded | Jonathan Siegal Principal Accounting Officer | SalePre-arranged (10b5-1) | 2,732 | $44.90 | $122.7K | 886 | |
traded | Sean C. Flynn Chief Legal Officer | SalePre-arranged (10b5-1) | 15,000 | $40.21 | $603.2K | 1,647 | |
traded | Michael Halpin Chief Operating Officer | SalePre-arranged (10b5-1) | 10,000 | $40.24 | $402.4K | 16,248 | |
traded | Jonathan Mark Hopper Chief Medical Officer | SalePre-arranged (10b5-1) | 4,375 | $35.00 | $153.1K | 75,753 | |
traded | Kevin F. Mclaughlin Director | SalePre-arranged (10b5-1) | 7,000 | $32.83 | $229.8K | 18,300 | |
traded | Paul K. Wotton Director | Sale | 10,000 | $32.74 | $327.4K | 26,302 | |
traded | Jonathan Siegal Principal Accounting Officer | SalePre-arranged (10b5-1) | 4,855 | $38.73 | $188.0K | 1,118 | |
traded | Joseph Anthony Mara Jr. Chief Financial Officer | SalePre-arranged (10b5-1) | 5,000 | $40.50 | $202.5K | 21,009 | |
traded | Jonathan Mark Hopper Chief Medical Officer | SalePre-arranged (10b5-1) | 3,472 | $35.00 | $121.5K | 75,556 | |
traded | Heidi Hagen Director | SalePre-arranged (10b5-1) | 15,000 | $32.41 | $486.1K | 31,850 | |
traded | Michael Halpin Chief Operating Officer | SalePre-arranged (10b5-1) | 10,305 | $35.30 | $363.8K | 16,080 | |
traded | Sean C. Flynn Chief Legal Officer | SalePre-arranged (10b5-1) | 21,421 | $35.18 | $753.5K | 1,262 | |
traded | Kevin F. Mclaughlin Director | SalePre-arranged (10b5-1) | 7,000 | $34.66 | $242.6K | 15,100 | |
traded | Michael Halpin Chief Operating Officer | SalePre-arranged (10b5-1) | 10,000 | $40.48 | $404.8K | 16,080 | |
traded | Paul K. Wotton Director | Sale | 5,000 | $37.90 | $189.5K | 25,602 | |
traded | Jonathan Mark Hopper Chief Medical Officer | SalePre-arranged (10b5-1) | 1,652 | $39.14 | $64.7K | 66,562 | |
traded | Michael Halpin Chief Operating Officer | SalePre-arranged (10b5-1) | 2,642 | $40.41 | $106.8K | 15,932 | |
traded | Kevin F. Mclaughlin Director | SalePre-arranged (10b5-1) | 7,000 | $38.59 | $270.1K | 15,100 | |
traded | Michael Halpin Chief Operating Officer | SalePre-arranged (10b5-1) | 7,358 | $40.47 | $297.8K | 15,932 |
GET /stocks/filings/vX/form-4?tickers=VCEL&filing_date.gte=2025-11-07&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"VCEL"
],
"issuer_cik": "0000887359",
"owner_cik": "0001214938",
"accession_number": "0001140361-26-033143",
"form_type": "4",
"filing_date": "2026-08-14",
"period_of_report": "2026-08-12",
"issuer_name": "Vericel Corp",
"issuer_trading_symbol": "VCEL",
"owner_name": "MCLAUGHLIN KEVIN F",
"is_director": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-08-12",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 7000,
"transaction_price_per_share": 44.53,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 18300,
"transaction_value": 311710,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025."
}
]
},
{
"tickers": [
"VCEL"
],
"issuer_cik": "0000887359",
"owner_cik": "0001778858",
"accession_number": "0001140361-26-031417",
"form_type": "4",
"filing_date": "2026-08-05",
"period_of_report": "2026-08-03",
"issuer_name": "Vericel Corp",
"issuer_trading_symbol": "VCEL",
"owner_name": "Halpin Michael",
"is_officer": true,
"officer_title": "Chief Operating Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-08-03",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 46.84,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 16394,
"transaction_value": 468400.00000000006,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025."
},
{
"id": "F1",
"description": "These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 78 records
- Option exercises56 records
- Tax withholding22 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has the Vericel Corporation's CEO sold stock?
No. Dominick Colangelo (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is VCEL’s insider data?
These are VCEL Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track VCEL insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for VCEL every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.